Physician profile
John D Mcbrayer
NPI 1508843061
$1,683.35
in general payments reported to CMS, 2019-2025
18 companies · $45.12 in 2025
The $45.12 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $101 · 2021: $229 · 2022: $509 · 2023: $537 · 2024: $116 · 2025: $45.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $285.21 | 2020-2023 | Gallant, Jot Dx |
| Pfizer INC. | $242.92 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $203.11 | 2021-2025 | Verquvo |
| Amgen INC. | $187.86 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $156.28 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $128.19 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $103.87 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $101.64 | 2019-2024 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $96.74 | 2022-2023 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $52.33 | 2021-2023 | Nexletol |
| Boston Scientific Corporation | $26.59 | 2019-2023 | |
| Acutus Medical, INC. | $21.87 | 2020 | |
| Angiodynamics, INC. | $15.43 | 2023 | Auryon Laser System 100-120 Vac |
| Novo Nordisk INC | $15.25 | 2022 | |
| Amarin Pharma, INC. | $14.94 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $13.76 | 2019 | |
| Lemaitre Vascular, INC. | $8.69 | 2023 | Artegraft Vascular Graft |
| Z-Medica, LLC | $8.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcbrayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.